Andrew Placzek

Andrew Placzek

Company: Schrodinger Inc

Job title: Principal Scientist


Discovery of Novel & Potent Inhibitors Targeting the NLRP3 Pathway 11:00 am

Using the physic-based computational platform, allied with machine learning techniques to enable the identification of NLRP3 inhibitors Highlighting the inhibitor’s capability to target both peripheral and CNS diseases Harnessing a range of functional and mechanistic cellular assays, in vivo pharmacodynamic and disease models to explore pathway inhibitionRead more

day: Conf Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.